Moleculin Announces Conference Call to Discuss FDA Filing and New Immune Checkpoint Data on Wednesday, December 12, 2018

World News: . []

HOUSTON Dec 06 2018 GLOBE NEWSWIRE -- Moleculin Biotech Inc Nasdaq MBRX Moleculin or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates all of which are based on license ag reement...

More news and information about Moleculin Biotech, Inc.

Published By:

Globe Newswire: 21:05 GMT Thursday 6th December 2018

Published: .

Search for other references to "moleculin" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us